CHINA SCAR TREATMENT MARKET ANALYSIS
Key Developments
Key players in the market are focused on conducting clinical trials to expand their product portfolio. For instance, HTC Corporation’s HTC VIVE, a VR system is under clinical trial for assessing the effect of virtual reality technology on decreasing the acute pain of scar treatment with fractional laser under local anesthesia. The study is expected to be completed in December 2020.
Major institutes in China are focused on R&D in treatment of caesarean section scars. For instance, in March 2019, Maternal and Child Health Hospital of Foshan completed a study that assessed the efficacy and safety of perinatal tissue mesenchyme stem cells in the treatment for caesarean section scars.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
